AI
Plan Ahead: Mastering Your AI Budget for 2025 Success
Stephen Tharp
Dotmatics
PAO-10-24-CL-06Oct 07, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07Jul 16, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06Jul 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09Jul 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10Jul 16, 2024
Women's Health
Revolutionizing Biologics (and Biology) through a Focus on Women
Chia Chia Sun; Gardiner Smith
Fab Biopharma
PAO-07-24-CL-03Jul 09, 2024
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.
Corning Life Sciences
PAO-09-23-CL-02Sep 29, 2023
Data Management
Who is Using FAIR Data in Life Sciences R&D Today?
Christian Olsen
Dotmatics
PAO-09-23-CL-05Sep 11, 2023
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
Christian Olsen
Dotmatics
PAO-07-23-CL-06Jul 17, 2023
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
Scorpius BioManufacturing
PAO-04-23-CL-01Apr 18, 2023
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03Mar 14, 2023
Prism Integration
Dotmatics Scientific R&D Platform Introduces Built-in GraphPad Prism Integrations
Dotmatics
PR-M02-23-01Feb 08, 2023
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05Feb 01, 2023
New Facility
Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin
Synbiotic Health
PR-M11-22-02Nov 02, 2022
mRNA
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-02Oct 11, 2022
Drug Discovery
Enabling Seamless Workflows for Small Molecule Drug Discovery
Melanie Nelson, Ph.D.
Dotmatics
PAO-08-022-CL-08Aug 23, 2022
R&D Data Management
Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving Therapies
Dotmatics
PR-M07-22-05Jul 19, 2022
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Avid Bioservices
PR-M06-22-02Jun 13, 2022
R&D
Driving Further Innovation by Integrating a Decentralized R&D Network
Giorgio Bertolini, Ph.D.
Olon
PAO-06-022-CL-02Jun 01, 2022
R&D
Olon Announces the Creation of a Major Center of Research and Development in Italy, That Will Give Rise to an Innovative Global R&D Model
Olon
PR-M05-22-10May 26, 2022